Comment by BurningFrog

Comment by BurningFrog 6 months ago

2 replies

The tradeoff with these price controls is that they make current medications cheaper, but make future medications substantially less profitable, making them less likely to be developed.

It's rare to see this mentioned, so I'm trying to build awareness.

thrance 6 months ago

You believe in a lie, most of the insane margins go towards sharholders of private laboratories or insurance companies and other parasites. Very little of it goes toward actual R&D, and the foundational part of it is done by public labs anyway, that are payed for by taxes.

  • BurningFrog 6 months ago

    Developing an approved drug costs 1-2 billion dollars.

    If you can't recoup that by selling the drug, developing drugs is not sustainable and will not happen. And the US is really the only country where you can sell for substantially more than manufacturing cost.

    Ozempic manufacturers do make huge profits now, but that's quite rare. This is a tough industry to make money in.